Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-15 Sale | 2025-12-16 5:07 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $30.02 | $255,130 | 392,642 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 4:24 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $25.19 | $214,091 | 401,142 (Direct) | View |
| 2025-10-15 Sale | 2025-10-16 4:30 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $25.79 | $219,196 | 409,642 (Direct) | View |
| 2025-09-15 Sale | 2025-09-17 4:15 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $24.19 | $205,649 | 418,142 (Direct) | View |
| 2025-08-15 Sale | 2025-08-18 5:14 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $15 | $127,466 | 426,642 (Direct) | View |
| 2025-07-15 Sale | 2025-07-16 4:14 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $14 | $118,962 | 435,142 (Direct) | View |
| 2025-06-16 Sale | 2025-06-18 4:15 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $11 | $93,522 | 443,642 (Direct) | View |
| 2025-05-15 Sale | 2025-05-19 4:30 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $9.5602 | $81,262 | 452,142 (Direct) | View |
| 2025-04-15 Sale | 2025-04-16 5:00 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $9.5659 | $81,310 | 460,642 (Direct) | View |
| 2025-03-14 Sale | 2025-03-17 5:00 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $10.85 | $92,205 | 469,142 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-03 Option Award | 2025-02-04 5:30 pm | N/A 2035-02-03 | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 7:43 pm | N/A 2034-06-05 | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 28,302 | $0 | 28,302 (Direct) | View |
Ownership | 2024-06-06 7:03 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 0 | $0 | 673,624 (Direct) | View |